249 related articles for article (PubMed ID: 22952854)
1. Inherited MST1 deficiency underlies susceptibility to EV-HPV infections.
Crequer A; Picard C; Patin E; D'Amico A; Abhyankar A; Munzer M; Debré M; Zhang SY; de Saint-Basile G; Fischer A; Abel L; Orth G; Casanova JL; Jouanguy E
PLoS One; 2012; 7(8):e44010. PubMed ID: 22952854
[TBL] [Abstract][Full Text] [Related]
2. Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infections.
Crequer A; Troeger A; Patin E; Ma CS; Picard C; Pedergnana V; Fieschi C; Lim A; Abhyankar A; Gineau L; Mueller-Fleckenstein I; Schmidt M; Taieb A; Krueger J; Abel L; Tangye SG; Orth G; Williams DA; Casanova JL; Jouanguy E
J Clin Invest; 2012 Sep; 122(9):3239-47. PubMed ID: 22850876
[TBL] [Abstract][Full Text] [Related]
3. Autosomal dominant epidermodysplasia verruciformis lacking a known EVER1 or EVER2 mutation.
McDermott DF; Gammon B; Snijders PJ; Mbata I; Phifer B; Howland Hartley A; Lee CC; Murphy PM; Hwang ST
Pediatr Dermatol; 2009; 26(3):306-10. PubMed ID: 19706093
[TBL] [Abstract][Full Text] [Related]
4. Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses.
Orth G
Semin Immunol; 2006 Dec; 18(6):362-74. PubMed ID: 17011789
[TBL] [Abstract][Full Text] [Related]
5. A novel approach to the classification of epidermodysplasia verruciformis.
Huang S; Wu JH; Lewis DJ; Rady PL; Tyring SK
Int J Dermatol; 2018 Nov; 57(11):1344-1350. PubMed ID: 30156265
[TBL] [Abstract][Full Text] [Related]
6. A homozygous nonsense mutation in the EVER2 gene leads to epidermodysplasia verruciformis.
Sun XK; Chen JF; Xu AE
Clin Exp Dermatol; 2005 Sep; 30(5):573-4. PubMed ID: 16045695
[TBL] [Abstract][Full Text] [Related]
7. Re-evaluation of epidermodysplasia verruciformis: Reconciling more than 90 years of debate.
Przybyszewska J; Zlotogorski A; Ramot Y
J Am Acad Dermatol; 2017 Jun; 76(6):1161-1175. PubMed ID: 28196644
[TBL] [Abstract][Full Text] [Related]
8. Epidermodysplasia verruciformis in a HIV-positive patient homozygous for the c917A-->T polymorphism in the TMC8/EVER2 gene.
Hohenstein E; Rady PL; Hergersberg M; Huber AR; Tyring SK; Bregenzer T; Streit M; Itin P
Dermatology; 2009; 218(2):114-8. PubMed ID: 19005244
[TBL] [Abstract][Full Text] [Related]
9. Do epidermodysplasia verruciformis human papillomaviruses contribute to malignant and benign epidermal proliferations?
Majewski S; Jablonska S
Arch Dermatol; 2002 May; 138(5):649-54. PubMed ID: 12020228
[TBL] [Abstract][Full Text] [Related]
10. [Pathogenesis of human papillomavirus infection in patients with epidermodysplasia verruciformis].
Liang S; Zuo YG; Wang BX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):93-6. PubMed ID: 19317070
[TBL] [Abstract][Full Text] [Related]
11. Identification of LCK mutation in a family with atypical epidermodysplasia verruciformis with T-cell defects and virus-induced squamous cell carcinoma.
Li SL; Duo LN; Wang HJ; Dai W; Zhou EH; Xu YN; Zhao T; Xiao YY; Xia L; Yang ZH; Zheng LT; Hu YY; Lin ZM; Wang HN; Gao TW; Ma CL; Yang Y; Li CY
Br J Dermatol; 2016 Dec; 175(6):1204-1209. PubMed ID: 27087313
[TBL] [Abstract][Full Text] [Related]
12. Host defenses against human papillomaviruses: lessons from epidermodysplasia verruciformis.
Orth G
Curr Top Microbiol Immunol; 2008; 321():59-83. PubMed ID: 18727487
[TBL] [Abstract][Full Text] [Related]
13. Identification of a novel mutation and a genetic polymorphism of EVER1 gene in two families with epidermodysplasia verruciformis.
Zuo YG; Ma D; Zhang Y; Qiao J; Wang B
J Dermatol Sci; 2006 Dec; 44(3):153-9. PubMed ID: 17008061
[TBL] [Abstract][Full Text] [Related]
14. Epidermodysplasia verruciformis in lipoid proteinosis: case report and discussion of pathophysiology.
O'Blenes C; Pasternak S; Issekutz A; Gillis J; Chowdhury D; Finlayson L
Pediatr Dermatol; 2015; 32(1):118-21. PubMed ID: 23534907
[TBL] [Abstract][Full Text] [Related]
15. Two sisters reveal autosomal recessive inheritance of epidermodysplasia verruciformis: a case report.
Yoshida R; Kato T; Kawase M; Honda M; Mitsuishi T
BMC Dermatol; 2014 Jul; 14():12. PubMed ID: 25048734
[TBL] [Abstract][Full Text] [Related]
16. Deficiency in
Torres AD; King RE; Uberoi A; Buehler D; Yoshida S; Ward-Shaw E; Lambert PF
J Virol; 2024 Jun; ():e0017424. PubMed ID: 38869286
[TBL] [Abstract][Full Text] [Related]
17. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis.
Ramoz N; Rueda LA; Bouadjar B; Montoya LS; Orth G; Favre M
Nat Genet; 2002 Dec; 32(4):579-81. PubMed ID: 12426567
[TBL] [Abstract][Full Text] [Related]
18. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients.
Berkhout RJ; Tieben LM; Smits HL; Bavinck JN; Vermeer BJ; ter Schegget J
J Clin Microbiol; 1995 Mar; 33(3):690-5. PubMed ID: 7751378
[TBL] [Abstract][Full Text] [Related]
19. [Genetics and susceptibility to human papillomaviruses: epidermodysplasia verruciformis, a disease model].
Orth G
Bull Acad Natl Med; 2010 Jun; 194(6):923-40; discussion 941. PubMed ID: 21513129
[TBL] [Abstract][Full Text] [Related]
20. EVER2 deficiency is associated with mild T-cell abnormalities.
Crequer A; Picard C; Pedergnana V; Lim A; Zhang SY; Abel L; Majewski S; Casanova JL; Jablonska S; Orth G; Jouanguy E
J Clin Immunol; 2013 Jan; 33(1):14-21. PubMed ID: 22903682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
